Clostridium difficile-Associated Disease in Patients in a Small Rural Hospital

Objective. To determine the risk factors for Clostridium difficile–associated disease (CDAD) in a 25-bed rural hospital and to compare antimicrobial use ratios at the study hospital with those at a large academic medical center. Design. Case-control study. Setting. A 25-bed rural hospital in Iowa during the period from August 2002 through January 2005. Patients. A total of 17 case patients with CDAD and 34 control patients matched for age (ie, within 10 years of the case patient's age), sex, and admission date (ie, within 2 weeks of the case patient's admission date). Methods. Retrospective medical record review was performed to obtain data on antimicrobial exposures during the 6 weeks before hospital admission for both case and control patients. Exact conditional logistic regression was used for univariable and multivariable analyses. Antimicrobial use ratios were calculated to compare the rates of antimicrobial use for case and control patients at the study hospital with the rates for patients evaluated in a study of CDAD at a nearly 700-bed teaching hospital. Results. Case patients had a larger cumulative number of days of antimicrobial use (P = .004), and they received a larger total number of antimicrobial agents during hospitalization (P = .001). Antimicrobial use ratios were higher for both case and control patients at the smaller hospital, compared with the larger hospital. Conclusions. CDAD at a small rural hospital was not associated with exposure to the antimicrobial classes that are typically associated with CDAD, but was instead related to the total number of antimicrobials used to treat patients. The rate of antimicrobial use for case and control patients was about 40% higher at the small rural hospital, compared with the corresponding rates at a large academic medical center.

[1]  T. Horan,et al.  Recommendations for Surveillance of Clostridium difficile–Associated Disease , 2007, Infection Control & Hospital Epidemiology.

[2]  J. Cavanaugh,et al.  An Outbreak of Severe Clostridium difficile–Associated Disease Possibly Related to Inappropriate Antimicrobial Therapy for Community-Acquired Pneumonia , 2007, Infection Control & Hospital Epidemiology.

[3]  P. Polgreen,et al.  Epidemiology of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus in a Rural State , 2006, Infection Control & Hospital Epidemiology.

[4]  M. Samore,et al.  Understanding Keys to Successful Implementation of Electronic Decision Support in Rural Hospitals: Analysis of a Pilot Study for Antimicrobial Prescribing , 2005, American journal of medical quality : the official journal of the American College of Medical Quality.

[5]  E. Wong,et al.  Varying Rates of Clostridium Difficile-Associated Diarrhea at Prevention Epicenter Hospitals , 2005, Infection Control & Hospital Epidemiology.

[6]  L. McDonald Clostridium difficile: Responding to a New Threat From an Old Enemy , 2005, Infection Control & Hospital Epidemiology.

[7]  G. Stoddard,et al.  Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci in Rural Communities, Western United States , 2005, Emerging infectious diseases.

[8]  Carlene A. Muto,et al.  A Large Outbreak of Clostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use , 2005, Infection Control & Hospital Epidemiology.

[9]  J. Gerberding,et al.  Pharmacist involvement in antimicrobial use at rural community hospitals in four Western states. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[10]  M. Loeb,et al.  Quinolone Use as a Risk Factor for Nosocomial Clostridium difficile-Associated Diarrhea , 2001, Infection Control & Hospital Epidemiology.

[11]  Y. Carmeli,et al.  Antibiotic prophylaxis and the risk of Clostridium difficile-associated diarrhoea. , 2001, The Journal of hospital infection.

[12]  A G Mainous,et al.  The Pharmacist's Role in Promoting Optimal Antimicrobial Use , 2000, Pharmacotherapy.

[13]  A. Shah,et al.  Diagnosis and treatment of Clostridium difficile colitis. , 1993, JAMA.

[14]  L. Peterson,et al.  Nosocomial Clostridium difficile colonisation and disease , 1990, The Lancet.

[15]  W. Stamm,et al.  Nosocomial acquisition of Clostridium difficile infection. , 1989, The New England journal of medicine.

[16]  L. Peterson,et al.  Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. , 1986, Archives of internal medicine.